It is important to note that probably not the JAK2 pathogenic variant itself has a causal effect on CTEPH manifestation, but its effects on increased erythrocytosis and increased risk of thrombosis may increase the likelihood of CTEPH development. This evidence concerns the gene JAK2 and Venous thrombosis.